The Centre for Genomic Regulation (CRG) and the biotechnology company Chemotargets have reached a collaboration agreement to facilitate and accelerate the process of searching for therapeutic targets and the subsequent drug development.
This initiative combines, on the one hand, the experience of the CRG in the identification of new therapeutic targets for diseases such as cancer, fibrosis, eye diseases, blood diseases or diseases that cause inflammation; and on the other, the cutting-edge technology, computational methods and data analysis offered by Chemotargets – a spin off of the Hospital del Mar Medical Research Institute (IMIM), another of the PRBB centers.
“Partnering with Chemotargets will be a vital boost to leverage our know-how for the benefit of patients in need”
Luis Serrano, director of the CRG.
The first common project will be focused on the CRG Cellular and Developmental Biology group led by Isabelle Vernos to study therapeutic targets related to infertility and cancer (processes related to cell division, area of expertise of the group).